Isleworth Healthcare (ISLE) to Combine with Cytovia Therapeutics in $367M Deal

Isleworth (NASDAQ:ISLE) has entered into a definitive agreement to combine with biopharmaceutical company Cytovia at an enterprise value of $367 million. The Aventura, Florida-based company is working to develop a range of therapies to treat liver cancer with modified natural killer cells. The combined company is expected to trade on the Nasdaq under the symbol
Read More